https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens. https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41071 20% in TC and TCH inroutine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 10 Jan 2024 11:15:37 AEDT ]]> A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51107 20% in TC and TCH in routine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 04 Oct 2023 11:54:27 AEDT ]]> Business as unusual: medical oncology services adapt and deliver during COVID-19 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46933 Thu 08 Dec 2022 13:52:16 AEDT ]]>